Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 7—July 2024
Research

Prevalence of and Risk Factors for Post–COVID-19 Condition during Omicron BA.5–Dominant Wave, Japan

Arisa IbaComments to Author , Mariko Hosozawa, Miyuki Hori, Yoko Muto, Isao Muraki, Rie Masuda, Nanako Tamiya, and Hiroyasu Iso
Author affiliations: National Center for Global Health and Medicine, Tokyo, Japan (A. Iba, M. Hosozawa, M. Hori, Y. Muto, H. Iso); Osaka University, Osaka, Japan (I. Muraki); University of Tsukuba, Ibaraki, Japan (R. Masuda, N. Tamiya)

Main Article

Figure 1

Flowchart of participant selection in study of prevalence and risk factors for post–COVID-19 condition during Omicron BA.5–dominant wave, Japan. Of 29,276 residents 20–69 years of age identified in the municipal HER-SYS database as infected with COVID-19, we selected a total of 25,911 participants; we extracted the same number of age- and sex-matched noninfected residents from the Basic Residence Registration System to serve as the control group. HER-SYS, Health Center Real-time Information-sharing System on COVID-19.

Figure 1. Flowchart of participant selection in study of prevalence and risk factors for post–COVID-19 condition during Omicron BA.5–dominant wave, Japan. Of 29,276 residents 20–69 years of age identified in the municipal HER-SYS database as infected with COVID-19, we selected a total of 25,911 participants; we extracted the same number of age- and sex-matched noninfected residents from the Basic Residence Registration System to serve as the control group. HER-SYS, Health Center Real-time Information-sharing System on COVID-19.

Main Article

Page created: June 05, 2024
Page updated: June 22, 2024
Page reviewed: June 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external